These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 8649465)

  • 1. Effect of dietary casein levels on activation of promutagens in the spiral Salmonella mutagenicity assay. II. Studies with induced rat liver S9.
    Woodall GM; Dauterman WC; DeMarini DM
    Mutat Res; 1996 Jun; 360(2):127-43. PubMed ID: 8649465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dietary casein levels on activation of promutagens in the spiral Salmonella mutagenicity assay. I. Studies with noninduced rat liver S9.
    Woodall GM; Dauterman WC; DeMarini DM
    Mutat Res; 1996 Jun; 360(2):115-26. PubMed ID: 8649464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosol is required for the modulation by dietary casein of the hepatic microsomal activation of aflatoxin B1 to mutagenic metabolites detectable in Salmonella.
    Woodall GM; Dauterman WC; Hagler WM; DeMarini DM
    Mutagenesis; 1999 Jul; 14(4):365-73. PubMed ID: 10390503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and detoxication of promutagens by toadfish (Opsanus tau) hepatic postmitochondrial fractions in the Salmonella assay.
    Milling DM; Maddock MB
    Mutat Res; 1986 Apr; 164(2):81-9. PubMed ID: 3515163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
    Traynor CA; Shane BS; Hajos AK; Winston GW
    Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promutagen activation by rodent-liver postmitochondrial fractions in the L5178Y/TK cell mutation assay.
    Amacher DE; Turner GN
    Mutat Res; 1980 Dec; 74(6):485-501. PubMed ID: 7464853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/beta-naphthoflavone or aroclor 1254 induced rat S-9.
    Johnson TE; Umbenhauer DR; Galloway SM
    Environ Mol Mutagen; 1996; 28(1):51-9. PubMed ID: 8698047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential activation of 6-aminochrysene and 2-aminoanthracene to mutagenic moieties by different forms of cytochrome P450 in hepatic 9000 X g supernatants from the rat.
    Lubet RA; McKinney CE; Cameron JW; Guengerich FP; Nims RW
    Mutat Res; 1989 Jun; 212(2):275-84. PubMed ID: 2659983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metyrapone on microsomal-dependent Salmonella mutagenesis. Studies with chloroallyl ethers and model compounds.
    Distlerath LM; Loper JC; Tabor MW
    Biochem Pharmacol; 1983 Dec; 32(24):3739-48. PubMed ID: 6661250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
    Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
    Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosolic activation of 2-aminoanthracene: implications in its use as diagnostic mutagen in the Ames test.
    Ayrton AD; Neville S; Ioannides C
    Mutat Res; 1992 Jan; 265(1):1-8. PubMed ID: 1370238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of rat liver cytochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods [corrected].
    Cancino-Badías L; Reyes RE; Nosti R; Pérez I; Dorado V; Caballero S; Soria A; Camacho-Carranza R; Escobar D; Espinosa-Aguirre JJ
    Mutagenesis; 2003 Jan; 18(1):95-100. PubMed ID: 12473742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promutagen activation with mammalian and avian S9 liver microsomes.
    Tometsko AM; Sheridan KM; DeTraglia MC
    J Appl Toxicol; 1981 Feb; 1(1):11-4. PubMed ID: 6309943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative mutagenicity tests in the Salmonella/microsome assay with rat and woodchuck S9 preparations.
    Rashid KA; Babish JG; Johnson BE; Mumma RO
    Toxicology; 1985 Aug; 36(2-3):139-46. PubMed ID: 3931301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the hepatic S9 fraction from aroclor-1254-treated rats on the mutagenicity of benzo[alpha]pyrene and 2-aminoanthracene in the Salmonella/microsome assay.
    Zeiger E; Chhabra RS; Margolin BH
    Mutat Res; 1979 Dec; 64(6):379-89. PubMed ID: 118381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
    Guobaitis RJ; Ellingham TJ; Maddock MB
    Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of mouse liver stored vitamin A on the induction of mutations (Ames tests) and SCE of bone marrow cells by aflatoxin B1, benzo(a)pyrene, or cyclophosphamide.
    Qin S; Huang CC
    Environ Mutagen; 1986; 8(6):839-47. PubMed ID: 3096708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody-directed analysis of cytochrome P-450-dependent monooxygenases and mutagen activation in the livers of DBA/2 and C57BL/6 mice.
    Hietanen E; Malaveille C; Friedman FK; Park SS; Béréziat JC; Brun G; Bartsch H; Gelboin HV
    Cancer Res; 1986 Feb; 46(2):524-31. PubMed ID: 3510075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay of phenacetin genotoxicity using in vitro and in vivo test systems.
    De Flora S; Russo P; Pala M; Fassina G; Zunino A; Bennicelli C; Zanacchi P; Camoirano A; Parodi S
    J Toxicol Environ Health; 1985; 16(3-4):355-77. PubMed ID: 3910846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S9 induction by the combined treatment with cyclohexanol and albendazole.
    Escobar-Garcia D; Camacho-Carranza R; Pérez I; Dorado V; Arriaga-Alba M; Espinosa-Aguirre JJ
    Mutagenesis; 2001 Nov; 16(6):523-8. PubMed ID: 11682644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.